Thanks to the The Wall Street Journal for covering PsyMed Ventures and our work in frontier neuroscience. We started PsyMed because brain and mental health need a new playbook. Neurological… | PsyMed Ventures

I get why there aren't more drugs for human enhancement available, things like attention, vigilance, and stress resilience. Outside of people with neurological disorders, our brains are already super… | Matias Serebrinsky | 20 comments

Matias Serebrinsky on Twitter / X

Matias Serebrinsky on Twitter / X

#neurotech #healthtech #startups #innovation #futureneuro | Albina K.

Matias Serebrinsky on Twitter / X

Matias Serebrinsky on Twitter / X

Brooks Leitner on LinkedIn: “Imprecision Medicine” “For every person they do help (blue), the ten… | 63 comments

Brooks Leitner on LinkedIn: Digital phenotyping from wearables using AI characterizes psychiatric…

Matias Serebrinsky on LinkedIn: Pretty obvious truth: every healthcare GTM channel sucks. - DTC: doesn’t… | 36 comments

Matias Serebrinsky on Twitter / X

Caitlin Ner on LinkedIn: AI Addiction: The Next Digital Epidemic

How neurotech + X can benefit mental illness | Greg Kubin posted on the topic | LinkedIn

The ADHD tech stack

Matias Serebrinsky on Twitter / X

Exploring the Next Generation of Mental Health Solutions

Matias Serebrinsky on LinkedIn: A healthcare investor asked me for POV about investing in therapeutics…

Transitioning from academia to startup

The Startup Landscape for Expanding Consciousness

Matias Serebrinsky on Twitter / X